Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Daratumumab Monotherapy for Patients with Relapsed or Refractory (R/R) Natural Killer/T-Cell Lymphoma (NKTCL), Nasal Type: Updated Results from an Open-Label, Single-Arm, Multicenter Phase 2 Study

Blood (2019) 134 (Supplement_1): 1568.

https://doi.org/10.1182/blood-2019-123446

Published: 2019

Journal Articles

Pomalidomide, Cyclophosphamide, and Dexamethasone for Elderly, Transplant-Ineligible Patients with Relapsed and/or Refractory Multiple Myeloma Who Had Failed Treatment with Lenalidomide and Bortezomib: A Study of the Korean Multiple Myeloma Working Party (KMMWP-164 study)

Ho Sup Lee, MD PhD, Chang-Ki Min, MD PhD, Kihyun Kim, MD, Seok Jin Kim, MD PhD, Je-Jung Lee, MD PhD, Inho Kim, MD PhD, Sung-Soo Yoon, MD PhD, Jin Seok Kim, MD PhD, Hyeon-Seok Eom, MD PhD, Dok Hyun Yoon, MD PhD, Cheolwon Suh, Ho-Jin Shin, MD PhD, Yeung-Chul Mun, MD, Min Kyoung Kim, MD PhD, Sung-Nam Lim, MD, Chul Won Choi, Hye Jin Kang, MD PhD

Blood (2019) 134 (Supplement_1): 3114.

https://doi.org/10.1182/blood-2019-122404

Published: 2019

Journal Articles

Bortezomib-Melphalan-Prednisone (VMP) Versus MP As Initial Treatment for Patients Older Than 75 Years with Newly Diagnosed Multiple Myeloma

Min Kyoung Kim, MD, Kihyun Kim, MD PhD, Dok Hyun Yoon, Cheolwon Suh, Jae Hoon Lee, MD, Sung-Hoon Jung, Je-Jung Lee, Hyo Jung Kim, Jin Seok Kim, Jeong-Ok Lee, Hyeon Seok Eom, MD PhD, Won Sik Lee, MD, Yeung-Chul Mun, Young Rok Do, Hye Jin Kang

Blood (2016) 128 (22): 5683.

https://doi.org/10.1182/blood.V128.22.5683.5683

Published: 2016

Journal Articles

Natural History of Relapsed Myeloma, Refractory to Immunomodulatory Drugs and Proteasome Inhibitors: A Multicenter IMWG Study

Shaji Kumar, MD, Meletios A Dimopoulos, Efstathios Kastritis, MD, Evangelos Terpos, Hareth Nahi, Hartmut Goldschmidt, MD, Jens Hillengass, MD, Xavier Leleu, Meral Beksac, MD, Melissa Alsina, MD, Albert Oriol, MD, Michele Cavo, MD, Enrique M. Ocio, MD PhD, Maria Victoria Mateos, Elizabeth K. O'Donnell, MD, Ravi Vij, MD MBA, Henk M. Lokhorst, MD PhD, Niels W.C.J. van de Donk, MD PhD, Chang-Ki Min, Tomer Mark, MD MSc, Ingemar Turesson, MD, PhD, Markus Hansson, MD, Heinz Ludwig, Sundar Jagannath, MD, Michel Delforge, MD PhD, Charalampia Kyriakou, MD PhD, Parameswaran Hari, MBBS, MD MRCP, Ulf-Henrik Mellqvist, MD PhD, Saad Z Usmani, MD FACP, Dominik Dytfeld, MD PhD, Ashraf Z Badros, MD, Philippe Moreau, Kihyun Kim, MD PhD, Paula Rodriguez Otero, MD, Jae Hoon Lee, MD, Chaim Shustik, MD, Daniel Waller, PhD, Wee Joo Chng, MD PhD, Shuji Ozaki, MD PhD, Je-Jung Lee, Javier de la Rubia, Hyeon Seok Eom, MD PhD, Laura Rosinol, MD PhD, Juan José Lahuerta, MD PhD, Anna Sureda, MD PhD, Jin Seok Kim, MD PhD, Brian G.M. Durie, MD

Blood (2016) 128 (22): 4414.

https://doi.org/10.1182/blood.V128.22.4414.4414

Published: 2016

Journal Articles

Hematopoietic Progenitor Cell Counts Is a Useful Indicator To Determine Appropriate Time For Peripheral Blood Stem Cell Collection

Sun-Young Kong, MD&PhD, Hyoeun Shim, MD, Se-Na Lee, Jung-Hee Kong, Hyeon-Seok Eom, MD&PhD, Byung-Kiu Park, MD&PhD, Hyeon Jin Park, MD&PhD, Tak Yun, MD&PhD, Hyewon Lee, MD, Yoon Kyung Song

Blood (2013) 122 (21): 2037.

https://doi.org/10.1182/blood.V122.21.2037.2037

Published: 2013

Journal Articles

Prognostic Implication Of Circulating Vascular Endothelial Growth Factor In Patients With Diffuse Large B-Cell Lymphoma

Hyewon Lee, MD, Hyeon-Seok Eom, MD&PhD, Min Kyeong Kim, Hyun-Ju Kim, Weon Seo Park, Sun-Young Kong, MD&PhD

Blood (2013) 122 (21): 3007.

https://doi.org/10.1182/blood.V122.21.3007.3007

Published: 2013

Journal Articles

Phase II Trial Of L-Asparaginase Plus Concurrent Chemoradiotherapy Followed By Midle (methotrexate, ifosfamide, etoposide, dexamethasone, and L-asparaginase) Chemotherapy For Patients With Newly Diagnosed Stage I/II Extranodal NK/T-Cell Lymphoma, Nasal Type

Seok Jin Kim, MD, PhD, Dok Hyun Yoon, MD, Seong Hyun Jeong, Dong-Yeop Shin, MD, Sung Hwa Bae, Junshik Hong, MD, Eun Kyung Park, Se Hyung Kim, Ho-Young Yhim, MD, Deok-Hwan Yang, MD, Hye Won Lee, Je-Jung Lee, MD, PhD, Mark Lee, MD, PhD, Hyeon Seok Eom, MD, PhD, Jae-Yong Kwak, MD, PhD, Jae Hoon Lee, Dae Sik Hong, Cheolwon Suh, Won Seog Kim

Blood (2013) 122 (21): 3037.

https://doi.org/10.1182/blood.V122.21.3037.3037

Published: 2013

Journal Articles

Prospective Cohort Study with Risk-Adapted Central Nervous System (CNS) Evaluation in Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP: Analysis of Incidence and Risk Factors for Secondary CNS Involvement.

Blood (2012) 120 (21): 2683.

https://doi.org/10.1182/blood.V120.21.2683.2683

Published: 2012

Journal Articles

Improved Survival of Patients with Multiple Myeloma and the Impact of Transplantation and Novel Agents: An Analysis of the Korean Multiple Myeloma Working Party (KMMWP).

Blood (2009) 114 (22): 4881.

https://doi.org/10.1182/blood.V114.22.4881.4881

Published: 2009

Journal Articles

Comparative Analysis of Outcomes of Allogeneic Peripheral Blood Stem Cell Transplantation From Related and Unrelated Donors.

Byung Woog Kang, M.D., Shi Nae Kim, M.D., Joon Ho Moon, M.D., Joo-Seop Jung, Goon-Jae Cho, Deog Yeon Jo, Yeo-Kyeoung Kim, Hyeoung Joon Kim, MD, Hun-Mo Ryoo, Hyeon Seok Eom, MD, PhD, Sang Min Lee, Young-Don Joo, Jong Ho Won, Moo-Rim Park, MD, Min Kyoung Kim, Myung Soo Hyun, MD, PhD, Sang Kyun Sohn, M.D.

Blood (2009) 114 (22): 3381.

https://doi.org/10.1182/blood.V114.22.3381.3381

Published: 2009

Journal Articles

Requirement for CD4 Help for Optimal GVL Effects of Alloreactive T Cells Given to Established Mixed Chimeras but Not Freshly Irradiated Mice.

Hyeon-Seok Eom, MD, PhD, Ronjon Chakraverty, MD, PhD, Jessica Sachs, MD, Guiling Zhao, Megan Sykes, MD

Blood (2004) 104 (11): 3044.

https://doi.org/10.1182/blood.V104.11.3044.3044

Published: 2004

NARROW

Daratumumab Monotherapy for Patients with Relapsed or Refractory (R/R) Natural Killer/T-Cell Lymphoma (NKTCL), Nasal Type: Updated Results from an Open-Label, Single-Arm, Multicenter Phase 2 Study

Pomalidomide, Cyclophosphamide, and Dexamethasone for Elderly, Transplant-Ineligible Patients with Relapsed and/or Refractory Multiple Myeloma Who Had Failed Treatment with Lenalidomide and Bortezomib: A Study of the Korean Multiple Myeloma Working Party (KMMWP-164 study)

Bortezomib-Melphalan-Prednisone (VMP) Versus MP As Initial Treatment for Patients Older Than 75 Years with Newly Diagnosed Multiple Myeloma

Natural History of Relapsed Myeloma, Refractory to Immunomodulatory Drugs and Proteasome Inhibitors: A Multicenter IMWG Study

Hematopoietic Progenitor Cell Counts Is a Useful Indicator To Determine Appropriate Time For Peripheral Blood Stem Cell Collection

Prognostic Implication Of Circulating Vascular Endothelial Growth Factor In Patients With Diffuse Large B-Cell Lymphoma

Phase II Trial Of L-Asparaginase Plus Concurrent Chemoradiotherapy Followed By Midle (methotrexate, ifosfamide, etoposide, dexamethasone, and L-asparaginase) Chemotherapy For Patients With Newly Diagnosed Stage I/II Extranodal NK/T-Cell Lymphoma, Nasal Type

Prospective Cohort Study with Risk-Adapted Central Nervous System (CNS) Evaluation in Diffuse Large B-Cell Lymphoma Patients Treated with Rituximab-CHOP: Analysis of Incidence and Risk Factors for Secondary CNS Involvement.

Improved Survival of Patients with Multiple Myeloma and the Impact of Transplantation and Novel Agents: An Analysis of the Korean Multiple Myeloma Working Party (KMMWP).

Comparative Analysis of Outcomes of Allogeneic Peripheral Blood Stem Cell Transplantation From Related and Unrelated Donors.

Requirement for CD4 Help for Optimal GVL Effects of Alloreactive T Cells Given to Established Mixed Chimeras but Not Freshly Irradiated Mice.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only